The Efficacy of Synthetic Oral Progestin Pills in Patients with Severe Endometriosis

In: Revista de Chimie · 2018 · vol. 69(6) , pp. 1411–1415 · doi:10.37358/rc.18.6.6335 · W3005271207
article OA: hybrid CC0 ⤵ 3 in-corpus citations
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-28

This paper reviews the efficacy of synthetic oral progestins, specifically dienogest 2mg daily, for reducing pain and endometrial lesions in patients with severe endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is an important public health issues concerning women of reproductive age due to its debilitating painful symptoms. Deep infiltrating endometriosis is the severe form, involving uterosacral ligaments, rectum, bowel and bladder. There is no optimal treatment for this disease, but there are 3 main therapeutic options: medical, surgical and a combination of both. A modern approach for the treatment of endometriosis pain uses dienogest, a progestin, as a long-term solution for women who do not wish to procreate or to whom surgery is not an option. Dienogest 2mg daily has a positive effect on the reduction of pain and endometrial lesions when used perioperatively or as a long-term postoperative treatment. This article focuses on the literature evidence on the efficacy of newly approved oral synthetic progestins in the treatment of severe endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisdie_deep_infiltrating

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK